Information  X 
Enter a valid email address

Galantas Gold Corp (GAL)


Wednesday 25 May, 2022

Galantas Gold Corp

Exercise of Warrants

RNS Number : 7830M
Galantas Gold Corporation
25 May 2022


Exercise of Warrants

May 25, 2022. Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) ("Galantas" or the "Company") announces the early exercise of 150,000 warrants at an exercise price of CAD$0.40 ("Warrants"). A total of 17,808,598, CAD$0.40 Warrants from the May 14, 2021, financing remain outstanding and are due to expire on May 14, 2023 (see May 18, 2021 news release).

150,000 Common Shares are expected to be admitted to trading on AIM on May 31, 2022 ("Admission").

Following Admission, the number of Common Shares in issue in the Company will increase to 83,166,801.

About Galantas Gold Corporation

Galantas Gold Corporation is a Canadian public company that trades on the TSX-Venture Exchange and the London Stock Exchange AIM market, both under the symbol GAL. It also trades on the OTCQX Exchange under the symbol GALKF. The Company's strategy is to create shareholder value by operating and expanding gold production and resources at the Omagh Project in Northern Ireland.


Galantas Gold Corporation 

Mario Stifano: Chief Executive Officer

Email: [email protected] 


Telephone: +44(0)28 8224 1100


Grant Thornton UK LLP (AIM Nomad) 

Philip Secrett, Harrison Clarke, George Grainger, Samuel Littler 

Telephone: +44(0)20 7383 5100 


Panmure Gordon & Co (AIM Broker & Corporate Adviser)

Nick Lovering, Hugh Rich, John Prior

Telephone: +44(0)20 7886 2500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t